Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Carboplatin/Paclitaxel in Advanced Endometrial Carcinoma
NCT00513786Phase 2Completed
- Start
- Aug 2007
- Primary completion
- Jan 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in endometrial carcinoma. Started Aug 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
endometrial carcinoma
Beyond the preview
Go deeper on NCT00513786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00513786.